BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/15/2019 6:26:39 AM | Browse: 1487 | Download: 3130
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 43026
Country Taiwan
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Observational Study
Article Title Risk of cholangiocarcinoma in patients undergoing therapeutic endoscopic retrograde cholangiopancreatography or cholecystectomy: A population based study
Manuscript Source Invited Manuscript
All Author List Chi-Chih Wang, Ming-Chang Tsai, Wen-Wei Sung, Tzu-Wei Yang, Hsuan-Yi Chen, Yao-Tung Wang, Chang-Cheng Su, Ming-Hseng Tseng and Chun-Che Lin
ORCID
Author(s) ORCID Number
Chi-Chih Wang http://orcid.org/0000-0002-8222-0503
Ming-Chang Tsai http://orcid.org/0000-0002-5770-9358
Wen-Wei Sung http://orcid.org/0000-0002-2375-0029
Tzu-Wei Yang http://orcid.org/0000-0002-1522-8177
Hsuan-Yi Chen http://orcid.org/0000-0003-1001-7968
Yao-Tung Wang http://orcid.org/0000-0002-0300-0896
Chang-Cheng Su http://orcid.org/0000-0002-7211-4192
Ming-Hseng Tseng http://orcid.org/0000-0001-8868-1610
Chun-Che Lin http://orcid.org/0000-0002-2474-6734
Funding Agency and Grant Number
Funding Agency Grant Number
Chung Shan Medical University Hospital CSH- 2013-C-032
Corresponding Author Chun-Che Lin, MD, PhD, Attending Doctor, Chief Doctor, Doctor, Doctor, Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chung Shan Medical University Hospital, No.110, Sec.1, Jianguo N.Rd., Taichung 40201, Taiwan. cshy333@csh.org.tw
Key Words Cholangiocarcinoma; Endoscopic sphincterotomy; Endoscopic papillary balloon dilatation; Cholecystectomy
Core Tip There are many risk factors well demonstrated in cholangiocarcinoma, but the impacts of advanced biliary interventions, like endoscopic sphincterotomy (ES), endoscopic papillary balloon dilatation (EPBD) and cholecystectomy, are inconsistence in previous literature. We tried to evaluate the subsequent cholangiocarcinoma risk in cholelithiasis patients who underwent ES, EPBD and cholecystectomy. Cholecystectomy can reduce the incidence of subsequent cholangiocarcinoma, while cholelithiasis patients underwent ES/EPBD are in a huge risk of subsequent cholangiocarcinoma in our database study.
Publish Date 2019-03-15 06:26
Citation Wang CC, Tsai MC, Sung WW, Yang TW, Chen HY, Wang YT, Su CC, Tseng MH, Lin CC. Risk of cholangiocarcinoma in patients undergoing therapeutic endoscopic retrograde cholangiopancreatography or cholecystectomy: A population based study. World Journal of Gastrointestinal Oncology 2019; 11(3): 238-249
URL https://www.wjgnet.com/1948-5204/full/v11/i3/238.htm
DOI https://dx.doi.org/10.4251/wjgo.v11.i3.238
Full Article (PDF) WJGO-11-238.pdf
Full Article (Word) WJGO-11-238.docx